
BICYCLE THERAPEUTICS PLC
BICYCLE THERAPEUTICS PLC (BCYC)
WebsitePrice
Market cap
Next catalystExpected 2H 2027zelenectide pevedotin — Duravelo-2 · Phase 2 dataCompany release ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
Partner / License out
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved